I dette studie blev der observeret arterielle tromboemboliske hændelser hos 11% (11/ 100) af patienterne i forhold til 5, 8% (6/ 104) i kemoterapikontrolgruppen.
In this trial arterial thromboembolic events were observed in 11% (11/ 100) of patients compared to 5.8% (6/ 104) in the chemotherapy control group.